http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1345358-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f88f84fc279fe5d0b9b5ec3c88c2e2b2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate | 1971-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1974-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1345358-A |
| titleOfInvention | Antiinflammatory preparations |
| abstract | 1345358 Anti-inflammatory preparations A H ROBINS CO Inc 8 Nov 1971 [16 Nov 1970] 51726/71 Heading A5B Anti-inflammatory preparations effective in preventing gastric irritation and bleeding of the gastric mucosa comprise a coprecipitate of an anti-inflammatory agent, such as aspirin, phenylbutazone or indomethacin, and a lignosulphonic acid or a salt thereof such as the ammonium, sodium, potassium, calcium, magnesium or lithium salt. The coprecipitate may be formed by acidifying an aqueous basic solution of an anti-inflammatory agent and a lignosulphonate and isolating the coprecipitate, e.g. by filtration or by spray drying. Pharmaceutical compositions for oral administration in the form of tablets or capsules comprise the coprecipitate and a carrier. The coprecipitate may comprise from 2 to 10% by weight of lignosulphonate. Suitable lignosulphonates are methanol-soluble or are those sold under the Trade Mark "Peritan". |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2229919-B |
| priorityDate | 1970-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.